Revvity Stock

Revvity EBIT

The EBIT of Revvity (RVTY) as of Aug 14, 2026 is 356.64 M USD. In the previous year, EBIT was 410.52 M USD — a change of -13.13% (lower).

EBIT

356.64 MUSD

YoY

-13.13%

Last updated:

In 2026, Revvity's EBIT was 356.64 M USD, a -13.13% increase from the 410.52 M USD EBIT recorded in the previous year.

The Revvity EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B USD)
Date
EBIT (B USD)
Jan 1, 2023
0.40 base
Jan 1, 2024
0.41 base
Jan 1, 2025
0.36 base
Jan 1, 2026 (e)
0.54 base
Jan 1, 2027 (e)
0.56 base
Jan 1, 2028 (e)
0.60 base
Jan 1, 2029 (e)
0.63 base
Jan 1, 2030 (e)
0.66 base
YEAREBIT (B USD)
2030 est 0.66
2029 est 0.63
2028 est 0.60
2027 est 0.56
2026 est 0.54
2025 0.36
2024 0.41
2023 0.40
2022 0.78
2021 1.34
2020 0.96
2019 0.41
2018 0.37
2017 0.30
2016 0.31
2015 0.27
2014 0.23
2013 0.26
2012 0.20
2011 0.12
2010 0.17
2009 0.14
2008 0.20
2007 0.17
2006 0.15
Access this data via the Eulerpool API

Revvity Revenue

Revvity Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
2.75 B USD
399.49 M USD
-118.38 M USD
Jan 1, 2024
2.76 B USD
410.52 M USD
295.83 M USD
Jan 1, 2025
2.86 B USD
356.64 M USD
241.68 M USD
Jan 1, 2026 (e)
2.85 B USD
536.12 M USD
606.50 M USD
Jan 1, 2027 (e)
3.00 B USD
564.21 M USD
668.02 M USD
Jan 1, 2028 (e)
3.15 B USD
597.84 M USD
730.16 M USD
Jan 1, 2029 (e)
3.34 B USD
633.43 M USD
789.59 M USD
Jan 1, 2030 (e)
3.49 B USD
661.11 M USD
851.94 M USD

Revvity Margins

Revvity stock margins

The Revvity margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Revvity. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Revvity.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
48.07 %
14.52 %
-4.30 %
Jan 1, 2024
48.01 %
14.90 %
10.74 %
Jan 1, 2025
53.08 %
12.49 %
8.46 %
Jan 1, 2026 (e)
53.08 %
18.81 %
21.27 %
Jan 1, 2027 (e)
53.08 %
18.78 %
22.24 %
Jan 1, 2028 (e)
53.08 %
18.95 %
23.15 %
Jan 1, 2029 (e)
53.08 %
18.95 %
23.63 %
Jan 1, 2030 (e)
53.08 %
18.95 %
24.42 %

Revvity Stock analysis

What does Revvity do? PerkinElmer Inc is an international company headquartered in Waltham, Massachusetts, USA. It provides solutions for improving health and the environment by offering instruments, consumables, software, and services in multiple industries. The company's history began in 1937 when Perkin-Elmer (named after two partners) was founded. It initially focused on manufacturing spectrometers and other instruments for chemical analysis. During World War II, Perkin-Elmer dramatically shifted its business towards the development of rocket sighting devices and aircraft parts. After the war, it returned to producing scientific equipment and began expanding into other markets. In the 1960s, Perkin-Elmer entered the field of medical diagnostics and started developing solutions for measuring hormones and proteins. Over the following decades, the company grew through expansion and acquisitions, including the purchase of Applied Biosystems, in areas such as molecular diagnostics, chromatography, genomics, and environmental analytics. PerkinElmer's business model focuses on providing solutions for customers in various fields such as pharma and biotechnology, environment and food, diagnostics, and clinical research. This includes instruments and consumables for analyzing proteins, nucleic acids, and other chemical substances, molecular diagnostic instruments and software, imaging systems for drug screening, and computer platforms for processing large amounts of data. The offered products and services of PerkinElmer encompass a wide range of solutions. The company's chromatography division offers instruments and consumables for the separation and analysis of chemical compounds. The Environmental Health division provides solutions for the identification and monitoring of pollutants in the environment, as well as for investigating food and drugs. The Analytical Sciences service division offers a wide range of analytical services to assist customers in solving research and development challenges. Other products and services of PerkinElmer include solutions for genomic analysis, drug development and manufacturing, diagnostic systems, laboratory automation, as well as software and services for data management. PerkinElmer is also a major provider of instruments and services in the field of medical imaging. One of PerkinElmer's standout products is its solutions for DNA and RNA sequencing. Using these technologies, researchers can identify genetic information that is crucial for disease diagnosis and treatment, as well as the development of new therapies and drugs. Overall, PerkinElmer offers a broad range of offerings aimed at improving health, the environment, and quality of life. The company works closely with customers in various industries to tailor its offerings to their needs. PerkinElmer is a key provider of solutions for improving health and the environment. The company offers a wide range of products and services, including instruments and consumables for chromatography, solutions for genomic analysis, and imaging systems for drug screening. Through its close collaboration with customers in various industries, PerkinElmer uses its knowledge and technology to make the world a better place. Revvity is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Revvity's EBIT

Revvity's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Revvity's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Revvity's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Revvity’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Revvity stock

EBIT of Revvity is 356.64 M USD in 2026.

EBIT of Revvity changed from 410.52 M USD to 356.64 M USD, representing a -13.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Revvity since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Revvity historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Revvity

All Key Metrics — Revvity